Brussels Metropolitan Area
Senior Life Sciences Executive, CEO and Board Member with more than 25 years of international leadership experience spanning medical devices, diagnostics and digital therapeutics. Proven track record in business transformation, organisational scale-up, fundraising, commercialisation and international expansion across start-ups, SMEs and global healthcare organisations. Successfully led turnarounds, growth initiatives and strategic repositioning programmes in both entrepreneurial and multinational environments. Held CEO, Chief Commercial Officer, General Manager and Board leadership roles, managing businesses exceeding $210 million in annual revenues and leading multidisciplinary teams of more than 150 employees across Europe and global markets. Recognised for combining strategic vision, commercial leadership and operational execution to build high-performing organisations and deliver sustainable growth. Internationally minded leader with extensive cross-cultural experience, having lived and worked in five countries and being fluent in Dutch, English, French and German. Passionate about helping innovative healthcare companies translate science and technology into meaningful patient impact and long-term value creation.
Managing and advising life sciences companies in the development and execution of their business strategies.
Turnaround and recapitalisation. International expansion and strategic repositioning. Development of an innovative rehabilitation technology portfolio, in compliance with European Medical Device Regulation (MDR). Company's transformation in close partnership with the founder/CTO and in full alignment with the company's board.
Global commercial leadership. Strategic growth and transformation initiatives. Development of the Genetics business franchise. Strengthening commercial capabilities across international markets. Member of the Group Executive Management Team.
Commercialisation strategy and global launch preparation for an innovative transcatheter heart valve platform. International business leadership and market development. Scaling commercial capabilities and organisational readiness. Member of the Executive Management Team.
Full P&L responsibility for a $210M endovascular business across Europe, leading an organisation of 150 employees. Transformation of the EMEA organisation from a regional to a divisional structure, accelerating growth from low single-digit to double-digit performance. Integration of Vessix Vascular and Bayer Interventional into the European business. Recipient of the 2014 Global Endovascular Leadership Award Runner-Up recognition.
Full P&L responsibility for a $132M business across the Benelux, leading an organisation of 90 employees. Leadership of strategic growth initiatives and business performance across the region. European lead for the transformation of the EMEA organisation from a regional to a divisional structure, in partnership with McKinsey, laying the foundations for the turnaround and accelerated growth of the European business.